Synthesis and SAR of 2-phenyl-1-sulfonylaminocyclopropane carboxylates as ADAMTS-5 (Aggrecanase-2) inhibitors

被引：19

作者：

Shiozaki, Makoto ^{[1
]}

Imai, Hiroto ^{[1
]}

Maeda, Katsuya ^{[1
]}

Miura, Tomoya ^{[1
]}

Yasue, Katsutaka ^{[1
]}

Suma, Akira ^{[1
]}

Yokota, Masahiro ^{[1
]}

Ogoshi, Yosuke ^{[1
]}

Haas, Julia ^{[2
]}

Fryer, Andrew M. ^{[2
]}

Laird, Ellen R. ^{[2
]}

Littmann, Nicole M. ^{[2
]}

Andrews, Steven W. ^{[2
]}

Josey, John A. ^{[2
]}

Mimura, Takayuki ^{[1
]}

Shinozaki, Yuichi ^{[1
]}

Yoshiuchi, Hiromi ^{[1
]}

Inaba, Takashi ^{[1
]}

机构：

[1] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Takatsuki Osaka 5691125, Japan

[2] Array BioPharma Inc, Boulder, CO 80301 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 21期

关键词：

SAR; ADAMTS-5 (Aggrecanase-2) inhibitors; 2-Phenyl-1sulfonylaminocyclopropanecarboxylates; LIGAND EFFICIENCY; CYCLOPROPANATION; ESTERS;

D O I：

10.1016/j.bmcl.2009.08.093

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of 1-sulfonylaminocyclopropanecarboxylates was synthesized as ADAMTS-5 (Aggrecanase-2) inhibitors. After an intensive investigation of the central cyclopropane core including its absolute stereochemistry and substituents, we found compound 22 with an Agg-2 IC(50) = 7.4 nM, the most potent ADAMTS-5 inhibitor reported so far. (c) 2009 Elsevier Ltd. All rights reserved.

引用

页码：6213 / 6217

页数：5

共 50 条

[21] The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation
Tortorella, MD
Malfait, AM
Deccico, C
Arner, E
OSTEOARTHRITIS AND CARTILAGE, 2001, 9 (06) : 539 - 552
[22] Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis
De Savi, Chris
Pape, Andrew
Sawyer, Yvonne
Milne, David
Davies, Chris
Cumming, John G.
Ting, Attilla
Lamont, Scott
Smith, Peter D.
Tart, Jonathon
Page, Ken
Moore, Peter
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (11) : 3301 - 3306
[23] 5-((1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one inhibitors of ADAMTS-5
Gilbert, Adam M.
Bursavich, Matthew G.
Lombardi, Sabrina
Georgiadis, Katy E.
Reifenberg, Erica
Flannery, Carl R.
Morris, Elisabeth A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) : 1189 - 1192
[24] Interaction with macrophages attenuates equine fibroblast-like synoviocyte ADAMTS5 (aggrecanase-2) gene expression following inflammatory stimulation
Morgan, Rhiannon E.
Clegg, Peter D.
Hunt, John A.
Innes, John F.
Tew, Simon R.
JOURNAL OF ORTHOPAEDIC RESEARCH, 2018, 36 (08) : 2178 - 2185
[25] New non-hydroxamic ADAMTS-5 inhibitors based on the 1,2,4-triazole-3-thiol scaffold
Maingot, Lucie
Leroux, Florence
Landry, Valerie
Dumont, Julie
Nagase, Hideaki
Villoutreix, Bruno
Sperandio, Olivier
Deprez-Poulain, Rebecca
Deprez, Benoit
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (21) : 6213 - 6216
[26] SYNTHESIS OF ETHYL 1-PHENYL-1-INDENE-2-CARBOXYLATES AND 1-ALKYL-1-INDENE-2-CARBOXYLATES
JALANDER, L
SYNTHETIC COMMUNICATIONS, 1988, 18 (04) : 343 - 349
[27] Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4)
Hashimoto, G
Aoki, T
Nakamura, H
Tanzawa, K
Okada, Y
FEBS LETTERS, 2001, 494 (03) : 192 - 195
[28] The synthesis and SAR of 2-arylsulfanyl-phenyl piperazinyl acetic acids as glyT-1 inhibitors
Smith, G
Ruhland, T
Mikkelsen, G
Andersen, K
Christoffersen, CT
Alifrangis, LH
Mork, A
Wren, SP
Harris, N
Wyman, BM
Brandt, G
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (15) : 4027 - 4030
[29] SYNTHESIS AND ADDITION-REACTIONS OF 2-PHENYL-1-CYCLOPROPENE-1-CARBOXYLATES
NORDEN, W
SANDER, V
WEYERSTAHL, P
CHEMISCHE BERICHTE-RECUEIL, 1983, 116 (09): : 3097 - 3111
[30] The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation (vol 9, pg 539, 2001)
Tortorella, MD
Malfait, AM
Deccico, C
Arner, E
Nagase, H
OSTEOARTHRITIS AND CARTILAGE, 2002, 10 (01) : 82 - 82

← 1 2 3 4 5 →